JEFFERIES ON PHARMA ; CRDMO SECTOR

• Focus on identifying future CRDMO winners. • India’s CRDMO sector has seen a resurgence, with listings of Sai Life, Anthem Bio, Cohance and Piramal Pharma. • Key challenge for investors is differentiating companies beyond financial performance. • Jefferies outlines six factors that drive long-term CRDMO success. • Divi’s Labs and Sai Life positioned ahead of peers. • Laurus Labs and Anthem Bio also rank strongly across several of these parameters.

← Back to feed